Financial News
Latest News about Mizuho Securities
Recent news which mentions Mizuho Securities
Arm Holdings Analysts Stay Bullish With Licensing Gains Overshadowing Royalty Concerns
November 09, 2023
From Benzinga
Affirm Holdings Boosts Profits Despite Choppy Macro: 5 Of 6 Analysts Revise Forecasts Post-FQ1
November 09, 2023
Tickers
AFRM
From Benzinga
Rivian Cruises With Open Options In EV Space, Not Just Amazon: 6 Analysts Peek Under the Hood Post-Q3
November 08, 2023
From Benzinga
Qualcomm Shares Surge On FQ4 Print: 5 Analysts Find The Spark In Results
November 02, 2023
From Benzinga
What 7 Analysts Think of Micron Technology's Q4: Excess Inventory, Product Demand
September 28, 2023
From Benzinga
From Benzinga
Boston Scientific's 'Next Level' Long-Term Plans: Why 2 Analysts Boost Price Targets
September 21, 2023
Tickers
BSX
From Benzinga
CrowdStrike's Fal.Con Event: AI Takes Center Stage, 6 Analysts Dive Deeper Into Tradeshow
September 21, 2023
Tickers
CRWD
From Benzinga
Why This DoorDash Analyst Is Turning Bullish, Upgrading Grocery Store Delivery App
September 18, 2023
Tickers
DASH
From Benzinga
Why This Adobe Analyst Is Turning Bullish Ahead Of Q3 Earnings
September 08, 2023
Tickers
ADBE
From Benzinga
Applied Materials' DRAM Revenues May Hit Record High: Analysts' Takeaways On FQ3 Print, Outlook
August 18, 2023
From Benzinga
BILL Holdings' Q4 Results: 6 Analysts Respond To Macro Headwinds Impacting Revenue Projections
August 18, 2023
From Benzinga
3 Rivian Analysts On Q2 Earnings: EV Production, Margins Shine, But Is 'Cash Burn' Ahead?
August 09, 2023
From Benzinga
Block's Stock Crashes Even After Beat-And-Raise Quarter, 5 Analysts Deep Dive Into Print
August 04, 2023
Tickers
SQ
From Benzinga
From Benzinga
Ahead Of Semiconductor Earnings, Analysts Expect AI To Serve As 'Shining Pillar' To Guide Through Muted Chip Demand
July 24, 2023
From Benzinga
From Benzinga
From Benzinga
5 Advanced Micro Devices Analyst Takeaways On AI Event: Is Chipmaker 'Somewhat Late' Vs. Rival Nvidia?
June 14, 2023
From Benzinga
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
May 23, 2023
Tickers
RAIN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
